Results 71 to 80 of about 4,728 (163)

Efficacy and safety of travoprost/timolol vs dorzolamide/timolol in patients with open-angle glaucoma or ocular hypertension

open access: yesClinical Ophthalmology, 2009
Miguel A Teus1, Stefano Miglior2, Guna Laganovska3, Lasma Volksone4, Bozena Romanowska-Dixon5, Roman Gos6, Gábor Holló7, for the C-05-25 Study Group81Hospital Príncipe de Astúrias, Universidad de Alcal& ...
Miguel A Teus   +3 more
doaj  

Topiramate‐induced acute angle closure with suprachoroidal effusion: Insights from a novel ultra‐wide‐field OCT device

open access: yes
Acta Ophthalmologica, Volume 104, Issue 3, Page e356-e359, May 2026.
Michael Hafner   +6 more
wiley   +1 more source

The short-term effect of topical dorzolamide compared with placebo on perimetry testing in normal subjects

open access: yes, 1996
Purpose. To study the effect of topical dorzolamide on retinal sensitivity in normal subjects. Methods. 20 normal subjects were prospectively randomized in a two period crossover study.
Hoop, J.   +4 more
core   +2 more sources

New RP-HPLC Method Development and Validation for Dorzolamide in Ophthalmic Dosage Form

open access: yesJournal of Analytical Methods in Chemistry, 2018
A reversed phase liquid chromatographic method with UV detection at 254 nm for dorzolamide assay in ophthalmic solutions was developed and validated. Chromatographic separation was achieved on a Zorbax SB C18 (250 mm × 4.6 mm, 5 µm) column kept at 30°C ...
Boovizhikannan Thangabalan   +2 more
doaj   +1 more source

Brinzolamide 1%/timolol versus dorzolamide 2%/timolol in the treatment of open-angle glaucoma or ocular hypertension: prospective randomized patient-preference study

open access: yes, 2015
Romeo Altafini,1 Maria-Luise Scherzer,2 Douglas A Hubatsch,3 Paolo Frezzotti4 1Glaucoma Segment Unit, “San Bortolo” Hospital, Vicenza, Italy; 2Private Practice, Regenstauf, Germany; 3Alcon Laboratories, Inc., Fort Worth, TX, USA; 4Ophthalmic
Scherzer ML   +3 more
core  

Efficacy of adjuvant topical timolol–dorzolamide with intravitreal bevacizumab injection in diabetic macular edema: A contralateral eye study

open access: yesJournal of Current Ophthalmology, 2019
Purpose: To assess the efficacy of adjuvant topical timolol–dorzolamide with intravitreal bevacizumab (IVB) injection on anatomic and functional results in eyes affected with diabetic macular edema (DME).
Ahmad Mirshahi   +4 more
doaj   +1 more source

Additive effect of latanoprost and dorzolamide in patients with elevated intraocular pressure

open access: yes, 1998
Purpose: To evaluate the additive ocular hypotensive effect of latanoprost and dorzolamide in combination, on intraocular pressure reduction in patients with elevated intraocular pressure (IOP).
Arici, MK, Topalkara, A, Guler, C
core   +1 more source

Patient perspectives when switching from Cosopt® (dorzolamide-timolol) to Azarga™ (brinzolamide-timolol) for glaucoma requiring multiple drug therapy

open access: yesClinical Ophthalmology, 2012
Graham Anthony Auger, Mathew Raynor, Simon LongstaffOphthalmology Department, Royal Hallamshire Hospital, Sheffield, South Yorkshire, United KingdomBackground: This study aimed to determine the impact of switching patients requiring multiple drug ...
Auger GA, Raynor M, Longstaff S
doaj  

Effects of dorzolamide/timolol fixed combination on retrobulbar hemodynamics in pseudoexfoliative glaucoma

open access: yesKaohsiung Journal of Medical Sciences, 2016
In our study we aimed to evaluate the short-term effects of dorzolamide/timolol on ocular perfusion pressure and retrobulbar blood flow in patients with pseudoexfoliative glaucoma (PXG).
Mustafa Eliacik   +5 more
doaj   +1 more source

Effect of Apraclonidine Versus Dorzolamide on Intraocular Pressure After Phacoemulsification

open access: yes, 2005
square BACKGROUND AND OBJECTIVE: To investigate the efficacy of 1% apraclonidine hydrochloride and 2% dorzolamide hydrochloride in controlling postoperative intraocular pressure elevation in patients undergoing ...
Sumru Onal   +5 more
core   +1 more source

Home - About - Disclaimer - Privacy